Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 4

2(28.6%)

Phase 1

1(14.3%)

7Total

N/A(4)

Phase 4(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT02000284Active Not Recruiting

Mitochondrial Dysfunction in Autism Spectrum Disorder

Role: collaborator

NCT00870064Not ApplicableRecruiting

The Treatment of Type I Open Fractures in Pediatrics

Role: collaborator

NCT05561764Phase 4Terminated

Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis

Role: collaborator

NCT03648710Not ApplicableCompleted

Community Health Workers and mHealth for Sickle Cell Disease Care

Role: collaborator

NCT02000167Completed

Mitochondrial Dysfunction in Phelan-McDermid Syndrome

Role: collaborator

NCT00777231Phase 1Completed

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

Role: collaborator

NCT02421120Phase 4Completed

Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients

Role: collaborator

NCT01745393Not ApplicableCompleted

Kids Safe and Smokefree (KiSS)

Role: collaborator

NCT01495611Completed

Multicenter Perioperative Opioid Pharmacogenetic Study

Role: collaborator

NCT02403466Not ApplicableCompleted

IIPE-PRIS Accelerating Safe Signouts

Role: collaborator

All 10 trials loaded